Status:
RECRUITING
Frailty in Patient Undergoing Percutaneous Left Atrial Appendage Closure.
Lead Sponsor:
Josep Rodes-Cabau
Conditions:
Transcatheter Left Atrial Appendage Closure
Frailty
Eligibility:
All Genders
18+ years
Brief Summary
To assess the prevalence and severity of frailty in patients undergoing LAAC, as well as its association to peri-procedural and long-term outcomes and quality of life.
Detailed Description
Transcatheter left atrial appendage closure (LAAC) has emerged as an alternative to anticoagulation for preventing thromboembolic events in patients with non-valvular atrial fibrillation and relative ...
Eligibility Criteria
Inclusion
- Transcatheter LAAC with any approved device
- Age ≥18 years old
Exclusion
- Unable to provide informed consent
- Severe neuropsychiatric impairment
Key Trial Info
Start Date :
March 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2029
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT05257954
Start Date
March 1 2022
End Date
March 1 2029
Last Update
December 20 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IUCPQ_UL
Québec, Quebec, Canada, G1V 4G5